Oncologists' Use of Twitter at Conferences
Mike Thompson, MD, PhD, from Stillwaters Cancer Support Services, discusses oncologists’ use of and attitudes towards Twitter.
Clinical Pearls
Mike Thompson, MD, PhD, from Stillwaters Cancer Support Services, discusses oncologists’ use of and attitudes towards Twitter.
- Thompson believes oncologists’ feelings towards social media have changed dramatically
- From 2011 to 2012, the growth in the number of Twitter users at ASH was small
- From 2012 to 2013, Twitter users at ASH increased from about 500 to about 1,200
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
